Previous Close | 30.80 |
Open | 31.06 |
Bid | 0.00 x 800 |
Ask | 32.35 x 800 |
Day's Range | 30.86 - 31.52 |
52 Week Range | 25.77 - 40.28 |
Volume | |
Avg. Volume | 2,014,398 |
Market Cap | 4.263B |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.03 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | 1.10 (3.48%) |
Ex-Dividend Date | Mar 07, 2024 |
1y Target Est | 38.50 |
Subscribe to Yahoo Finance Plus to view Fair Value for PRGO
A closer look at one of the leaders in the global over-the-counter pharmaceuticals market
Perrigo Company plc (NYSE:PRGO) Q4 2023 Earnings Call Transcript February 27, 2024 Perrigo Company plc beats earnings expectations. Reported EPS is $0.86, expectations were $0.83. PRGO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the […]
The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin. Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription.